COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01941316
Recruitment Status : Unknown
Verified October 2017 by Cancer Research and Biostatistics Clinical Trials Consortium.
Recruitment status was:  Recruiting
First Posted : September 13, 2013
Last Update Posted : November 7, 2017
Lucille P. Markey Cancer Center at University of Kentucky
Washington University School of Medicine
Information provided by (Responsible Party):
Cancer Research and Biostatistics Clinical Trials Consortium

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2018